A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma

170Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

To clarify the role of thermoradiotherapy for FIGO Stage IIIB cervical carcinomas, both the clinical response and survival of patients treated with radio- or thermoradiotherapy were investigated. Forty patients with Stage IIIB uterine cervix carcinoma were treated with external beam irradiation to the pelvis, combined with iridium 192 high-dose-rate intracavitary brachytherapy. All patients were divided randomly into the following two groups: the radiotherapy (RT) group of 20 patients, who underwent radiotherapy alone; and the thermoradiotherapy (TRT) group of 20 patients, who underwent three sessions of hyperthermia in addition to radiotherapy. The primary endpoint of this study was local complete response and survival. A complete response was achieved in 50% (10 of 20) in the RT group versus 80% (16 of 20) in the TRT group (p = 0.048). The 3-year overall survival and disease-free survival of the patients who were treated with TRT (58.2 and 63.6%) were better than those of the patients treated with RT (48.1 and 45%), but these differences were not significant. The 3-year local relapse-free survival of the patients who were treated with TRT (79.7%) was significantly better than that of the patients treated with RT (48.5%) (p = 0.048). TRT, as delivered in this trial, was well tolerated and did not significantly add to either the relevant clinical acute or long-term toxicity over radiation alone. TRT resulted in a better treatment response and 3-year local relapse-free survival rate than RT for patients with FIGO Stage IIIB cervical carcinoma.

References Powered by Scopus

Nonparametric Estimation from Incomplete Observations

50807Citations
N/AReaders
Get full text

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

2378Citations
N/AReaders
Get full text

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

2047Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Hyperthermia in combined treatment of cancer

1802Citations
N/AReaders
Get full text

The cellular and molecular basis of hyperthermia

1517Citations
N/AReaders
Get full text

Heating the patient: A promising approach?

1061Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Harima, Y., Nagata, K., Harima, K., Ostapenko, V. V., Tanaka, Y., & Sawada, S. (2001). A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. International Journal of Hyperthermia, 17(2), 97–105. https://doi.org/10.1080/02656730010001333

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

73%

Researcher 2

18%

Lecturer / Post doc 1

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

50%

Computer Science 2

20%

Engineering 2

20%

Chemical Engineering 1

10%

Save time finding and organizing research with Mendeley

Sign up for free